China SXT Pharmaceuticals (2RY3) Revenue
China SXT Pharmaceuticals Revenue
China SXT Pharmaceuticals had a revenue of 1.20M in the quarter ending Mar 31, 2026, with 368.63%. This bring the company's revenue in the last twelve months to 1.07M, Increased 225.17%. In the fiscal year ending Mar 31, 2026, China SXT Pharmaceuticals had annual revenue of 1.07M with -38.39% growth.
- Revenue (ttm)
- 1.07M
- Revenue Growth
- -39.44%
- P/S Ratio
- 1.86
- Revenue/Employee
- EUR 19,154
- Employees
- 56
- Market Cap
- EUR 2.00M
Revenue Chart
China SXT Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.07M | -668.27K | -38.39% |
| Mar 31, 2025 | 1.74M | -187.59K | -9.73% |
| Mar 31, 2024 | 1.93M | -43.18K | -2.19% |
| Mar 31, 2023 | 1.97M | -630.60K | -24.23% |
| Mar 31, 2022 | 2.60M | -2.18M | -45.53% |
| Mar 31, 2021 | 4.78M | -384.69K | -7.45% |
| Mar 31, 2020 | 5.16M | -1.85M | -26.38% |
| Mar 31, 2019 | 7.01M | -7.22K | -0.10% |
| Mar 31, 2018 | 7.02M | 2.14M | 43.79% |
| Mar 31, 2017 | 4.88M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.